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This article is in response to the challenge issued to the scientific community by the National
Toxicology Program to predict the carcinogenicity potential of 30 chemicals previously selected
for long-term carcinogenicity testing. Utilizing the available toxicologic, genetic, and structural
information on 30 chemicals previously selected for long-term carcinogenicity testing, we predict
that 16 chemicals (53%) would induce some indication of carcinogenic activity in rodents; we
further predict that 10 chemicals (33%) would be associated with weak or equivocal carcinogenic
responses, and another 4 (13%) would give no indication of carcinogenicity. Our level of certainty
is indicated for many of these predictions. Nonetheless, we believe that most instances of
guessing whether a chemical would eventually induce cancer in experimental animals and hence
represent a carcinogenic hazard to humans are fraught with considerable uncertainty: uncertainty
that can only be relieved by long-term testing for carcinogenicity in animals or by conducting an
epidemiologic investigation of exposed individuals or groups. We further believe that the day may
come when our predictive acumen will be upgraded to such an extent that we might eventually
obviate cancer testing. Until then, and in the best interests of public health, however, we urge
long term testing of chemicals in animals be continued, at increased pace. Environ Health
Perspect 104(Suppl 5):1105-1112 (1996)
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Introduction
A formidable challenge among health
professionals centers on the ability to pre-
dict, with reasonable accuracy, toxicologic
and carcinogenic activities of exposure
circumstances without actually having to
conduct experimental research deemed
necessary and essential to identify human
health hazards. Humans and most other
species are exposed to a plethora of both
natural and synthetic chemicals in myriad,
complex, and matrixal compositions (1,2).
Unfortunately, most risk assessments are
done on single entities that typically have
little to do with real exposures. Most of
these assessments come historically from
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experimental carcinogenicity studies and
testing on single chemicals (3). Both now
and in the future, more emphasis must be
given to studying both simple and complex
mixtures, as well as consumer, environ-
mental (e.g., home), and occupational and
workplace exposure circumstances (4).
In this article, we are responding to the
challenge of the National Toxicology
Program (NTP) to the scientific commu-
nity to predict the carcinogenicity potential
of 30 chemicals currently being tested by
the NTP. Our predictions (read, "educated
estimates or guesses") are based on avail-
able data on other chemicals and short
term testing data on the 30 chemicals.
Much ofour educated estimating or guess-
ing involved what we know already about
other chemicals or metabolites that have
been tested. These data include structure-
activity relationships, physical and chemical
properties, classes of agents (e.g., nitrosa-
mines, aromatic amines, anthraquinones,
and others known to be carcinogenic);
mutagenicity and genetic toxicity; meta-
bolic activation to reactive molecules (e.g.,
epoxides); mechanisms of carcinogenesis,
and preneoplastic or neoplastic indicators
identified in shorter term toxicity experi-
ments. These criteria have been summa-
rized, most notably by Weisburger (5),
Fung et al. (6), and Woo et al. (7).
The newest entry into this prediction
melange is mechanism (8-12); yet mecha-
nisms of carcinogenesis, albeit exciting,
remain virtually futuristic and must receive
continuing study and verification before
acceptance into the scientific, regulatory, and
legislative complex (13-15). Unfortunately
this has happened already.
We also include in this article the pre-
dictions of the National Cancer Institute
(NCI) Chemical Selection Working Group
(CSWG), which nominated 25 of the 30
chemicals for carcinogenicity testing. The
CSWG has been in existence since the early
1970s. It is an interagency group offederal
scientists that currently operates under the
auspices of the Chemical and Physical
Carcinogenesis Branch, Division of Cancer
Biology, NCI. The CSWG serves as an
evaluation committee in the NCI chemical
selection process for nominating chemicals
for carcinogenicity and other toxicity test-
ing; reported to the NCI before 1978, and
since then to the NTP. Because the CSWG's
predictions were based on a much smaller
database than that available to the current
predictors, we thought it would be interest-
ing to compare the success ofthe CSWG's
predictive rate with that of the other
participants in the NTP challenge exercise.
We surmise that one of the reasons for
this challenge exercise is to determine how
good the various predictive methodologies
are and their potential for replacing the
bioassay. Therefore, we thought it would
be remiss not to emphasize that the bioas-
say is still the best way to ascertain whether
a chemical is carcinogenic in rodents and
that it would be unwise to decide against
testing based on information from short-
term studies. Accordingly, in the discussion
section we provide examples of chemicals
that were found to be carcinogenic in
bioassays but for which there were no sug-
gestions of carcinogenic activity in the
short-term studies, and chemicals that were
found to be noncarcinogenic but for which
there were suggestions of carcinogenicity
potential from the short-term studies.
Methods
In addition to the comments in the preced-
ing paragraph, many computerized meth-
ods are currently used for predicting
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carcinogenic potential of agents not yet
tested. In a previous NTP challenge exer-
cise on 44 chemicals being tested, the most
successful predictive rate was reported to
be that of "human experts" (16-18). Not
surprising, the ability of computer models
to predict carcinogenicity can only be as
good as the dataset on which each method
was based. As we have learned and were
prepared for in advance, it is exceedingly
difficult to create machine/computer meth-
ods that incorporate all the various factors
and biological modalities and idiosyncrasies
that need to be considered in predicting
carcinogenicity ofchemicals (4,14).
So far, ofthe computer models available,
the U.S. Environmental Protection Agency's
Expert Oncologic System appears to come
closest to bringing together the parameters
used typically by a human expert.
Further, if one does concentrate on
computer-prediction models, one should
remain critical of results that may be con-
trary to established scientific thought; that
is, computers are often wrong. Thus, it is
clear that computer predictions should be
scrutinized by human experts regarding
both logical and scientific sense. Obviously,
then, there is still a vital need for scientific
intuition that is lacking in computerized
models. With this in mind, and calling our-
selves human experts, we attempted to
utilize the totality-of-information approach
to predict the potential carcinogenicity of
30 chemicals that are currently being
tested or whose long-term studies were
recently completed. Our predictions are
based mainly on the criteria briefly men-
tioned above and described in more detail
below, and on our scientific intuition-or
naivete-when there are insufficient or
inadequate data available.
The criteria used to assign suspicion of
carcinogenicity to a chemical included
* positive or suggestive results from pre-
vious experimental studies in animals or
epidemiological studies
* close structural relationship to known
carcinogens or chemical classes of car-
cinogens
* potential to act directly as an elec-
trophilic agent or to be metabolized to
an electrophilic species
* potential to act as a DNA intercalating
agent
* potential to be metabolized to active
free radical species
* positive results from mutagenicity studies
(e.g., in Salmonella typhimurium).
Information on the absorption, distri-
bution, metabolism and excretion of
chemicals was also considered in the
evaluation ofthe carcinogenic potential of
the candidate chemicals. Thus, physical
properties such as solubility in water and
organic solvents; partition coefficients;
and vapor pressure, which impact on the
bioavailability of the chemicals were also
given consideration.
For some chemicals, we elected to pre-
dict equivocal results because both toxic
and detoxication mechanisms may be oper-
ative, and we were not able to estimate
which would be the dominant mechanism.
Results
At the time of nominating and selecting
chemicals for toxicologic characterization,
including carcinogenesis, the CSWG typi-
cally rendered a guess-or prediction-for
carcinogenic potential ofthe selected chem-
ical. The CSWG's predictions were based
on the criteria described above; however, at
the time ofdoing this there was very little
or no biologic or toxicologic information
available on these chemicals. Table 1 lists
the 30 chemicals and the CSWG's predic-
tions: The CSWG did not evaluate 5 of
the chemicals and therefore recorded no
judgment on them; for the remaining 25,
16 were predicted to be carcinogenic
(64%), 8 were considered unknown (32%),
and one (xylenesulfonic acid, sodium) was
considered to be noncarcinogenic (4%).
Obviously this reflects the policy, which
was prevalent at that time, ofselecting and
testing chemicals most likely to present
carcinogenic risks to humans (6,19).
Nearly two decades later, on the basis
of our intuitive sense and experience in
evaluating chemicals for carcinogenic activ-
ity, and the availability of much more
biologic and toxicologic information, we
believe 16 ofthe 30 chemicals (53%) would
be carcinogenic to one or more of the
experimental groups configured in the typi-
cal two-species bioassay (3,4,20); 4 of the
30 chemicals (13%) would be noncarcino-
genic, and 10 (33%) would be equivocal or
weakly carcinogenic (Table 1). The three
tabular columns contain the alphabetical
listing of chemicals, with CAS registry
numbers and the route of exposure; our
predictions together with the rationale for
this decision, as well as supplementary deci-
sion making comments; and the historic
CSWG earlier predictions.
For several of these chemicals our
placement into a particular category was
more certain than for others. Some predic-
tions were particularly difficult and repre-
sent real or significant guesses. In a few
cases, disagreement among us remains; and
these received consensus based on compro-
mise and majority rules. For these few, we
await the test results to learn who was the
correct predictor.
We attempted initially to predict car-
cinogenic potential of these chemicals by
individual species, strain, and gender: male
rats, female rats, male mice, female mice.
This proved to be unsatisfactory to us and
was abandoned, for the most part, as being
particularly fanciful. Thus, except where
specified, our predictions are given on a
chemical basis and not on each ofthe four
individual experimental test units within
that chemical bioassay. In certain instances
we thought to follow various indicators
(e.g., aliphatic solvents typically cause liver
tumors in mice and perhaps kidney tumors
in male rats) gleaned from previous bioas-
says, but even with these cases we decided
this would be frivolous.
Discussion and Conclusions
In our view, except in rare cases these pre-
dictions, while being intellectually interest-
ing and enjoyable, do not and likely will
not replace eventual in vivo testing (2,4,6,
14,19,21,22). We offer here a few exam-
ples ofchemicals that were tested although
there was no way to anticipate the results.
No one predicted that phthalates (di-2-eth-
ylhexyl phthalate) would be carcinogenic
in long-term exposure studies (23-25);
however, the findings ofcarcinogenicity for
the phthalates led to a large research effort
directed toward mechanistic relevance of
chemicals causing peroxisome proliferation.
We were reproved for testing, among other
chemicals, d-limonene; yet this oil-of-orange
induced tumors ofthe kidneys in male rats
(26), concomitantly associated with a
testoster one-stimulated protein (@i2p glob-
ulin) that purportedly plays some mechanis-
tic role in this lesion (27-31). Again these
testing results-as well as findings for
unleaded gasoline-stimulated much
research into mechanisms. Also, so-called
nongenotoxic carcinogens (32) identified in
long-term bioassays have generated much
speculation and hypotheses into mecha-
nisms. Both di-2-ethylhexyl phthalate and
d-limonene are nongenotoxic; hence other
mechanisms are sought for their activity.
Much of this effort centers on the asso-
ciation or lack thereof of chemically
induced toxic lesions leading to or progress-
ing to benign and malignant tumors. Most
large studies find little or no correlation
or consistency between toxicity and car-
cinogenicity (28,33,34). Often empirical
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Table 1. Authors' and NCI Chemical Selection Working Group's predictions.
Chemical
CAS number Authors' predictions; NCI CSWG's
Route of exposure Rationale/Comments Predictions
Anthraquinone Noncarcinogenic Carcinogenic
t-Butylhydroquinone
1948-33-Oa
Feed
1-Chloro-2-propanol
127-00-4a
Drinking water
Chloroprene
126-99-8a
Inhalation
Cinnamaldehyde
104-55-2
Feed
Citral
5392-40-5
Feed
Cobalt sulfate heptahydrate
10026-24-1 a
Inhalation
Anthraquinone is metabolized to 2-hydroxyanthraquinone, which may be expected to be excreted via
conjugation.
Mutagenic; induced in vivomicronuclei.
Although several anthraquinones were carcinogenic in NTP studies, these compounds had amino
substituents and the observed carcinogenic effects may be attributed to the aromatic amine functionality
rather than to the hydroquinone moiety.
Hydroxyanthraquinones that are carcinogenic are substituted in the 1- or 8-position and mayform a pyrene-
type compound via hydrogen bonding ofthe hydroxy group and carbonyl function
Equivocal
Induced chromosomal aberrations (CAs) and sister chromatid exchanges (SCEs) in Chinese hamster ovary
(CHO) cells.
Hyperplasia observed in subchronic studies (male and female rats: hyperplasia of nasal respiratory
epithelium; male and female rats: hyperplasia of skin and forestomach).
Possibility of excretion via conjugation.
Carcinogenic
Mutagenic and clastogenic; negative in vivo micronucleus assay.
Alkylating agent.
Suggestive positive results from previous studies.
Note: Drinking water studies are rarely positive.
Carcinogenic
Genotoxic.
Structurally related tovinyl chloride and butadiene, known human and rodent carcinogens.
Carcinogenic
Weakly mutagenic.
Alkylating agent; potential forforming iminium compound with DNA.
Hyperplasia ofthe forestomach mucosa observed in both sexes of rats and mice in a microencapsulation
subchronic study.
Carcinogenic
Nongenotoxic (SCEs in CHO).
Potential alkylating agent; formation of iminium compound with DNA.
Estrogenic activity.
Sebaceous gland hyperplasia observed aftertopical application.
Equivocal
Weakly positive in SA.
Previous studies indicated local sarcomas.
Subchronic studies indicate proliferation, inflammatory and metaplastic changes in rats and mice.
Essential micronutrient at physiological levels but may be carcinogenic at high levels.
Did not consider
Carcinogenic
Carcinogenic
Carcinogenic
Carcinogenic
Carcinogenic
Noncarcinogenic
Nongenotoxic (SCEs in CHO).
Although there is potential for epoxide formation, and formation of a secondary amine which may be
nitrosated, it is known thatthe main metabolic pathway for codeine is conjugation and excretion.
Codeine and its metabolites are rapidly excreted within 24 hr. No nitrosated product was found.
Unknown suspicion
D&C Yellow No. 11
8003-22-3a
Feed
Diethanolamine
1 1-42-2a
Dermal
1,2-Dihydro-2,2,4-
trimethylquinoline
147-47-7a
Dermal
Equivocal
Positive results in mutagenicity and clastogenicity studies but did not induce in vivomicronuclei.
Structurally related to quinoline, a rodent carcinogen.
Carcinogenic
Nongenotoxic.
Potential forforming nitrosamine, namely, N-nitrosodiethylolamine, a liver and nasal carcinogen in rats.
Carcinogenic
Increase in micronuclei seen in in vivo 90-day mouse study.
In vitroSCE increase.
Structurally related to quinoline, and suggestive positive results from earlier studies.
(Continued)
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Feed
Codeine
76-57-3a
Feed
Did not consider
Carcinogenic
Carcinogenic
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Table 1.(Continued.)
Chemical
CAS number Authors' predictions; NCI CSWG's
Route of exposure Rationale/Comments Predictions
Emodin Carcinogenic Did not consider
Ethylbenzene
100-41 4a
Inhalation
Ethylene glycol monobutyl ether
111-76-2a
Inhalation
Mutagenic, clastogenic and induced micronuclei.
Emodin would be expected to form a glucuronide and subsequent facile excretion. However, there is some
evidence forthe tumor promoting carcinogenicity ability of hydroxyanthraquinones.
1- or8-Hydroxyanthraquinones mayform a pyrenetype structure via hydrogen bonding ofthe hydroxy and
carbonyl functions.
Equivocal
Not mutagenic.
Metabolized to a-methylbenzyl alcohol, which showed some evidence of carcinogenicity in male rats.
Noncarcinogenic
Nongenotoxic.
No structural alert.
Did not consider
Did not consider
Furfuryl alcohol
98-00-0a
Inhalation
Gallium arsenide
1303-00-0
Inhalationa
Isobutene
115-11-7a
Inhalation
Isobutyraldehyde
78-84-2a
Inhalation
Methyleugenol
93-15 2a
Gavage
Molybdenum trioxide
1313 27-5a
Inhalation
Nitromethane
75-52-5a
Inhalation
Oxymetholone
434-07-1a
Gavage
Carcinogenic
Nongenotoxic.
Induced SCEs in CHO cells.
Structurally related tofuran, which was carcinogenic in NTP studies. Carcinogenic effectexpected to
resultfrom formation ofepoxide.
Equivocal
Nongenotoxic.
Prediction is based on results of subchronic studies, for example, bone marrow hyperplasia in rats and
pulmonary hyperplasia in mice.
Carcinogenic
Nongenotoxic.
Potential forformation ofepoxide.
The epoxide of isobutene was mutagenic in Salmonella assay.
Isobutene is a potential metabolite of methyl t-butyl ether, which is a rodent carcinogen.
Carcinogenic
Mutagenic and clastogenic.
Potential alkylating agent-formation of iminium compound with DNA.
It is possible thatthe length ofthe side chain may reduce the activity ofthe aldehyde function.
Isobutyraldehyde was nominated to investigate this possibility.
Carcinogenic
Nongenotoxic (SCEs in CHO).
Structurally related to safrole and estragole, known rodentcarcinogens.
Potential forformation ofepoxide.
Biliary hyperplasia observed in mice in subchronic studies.
Eugenol was noncarcinogenic in NTP studies. In eugenol, the hydroxy substituents afforded a detoxifying
mechanism via conjugation and ready excretion. In methyl eugenol, the hydroxyl groups are replaced by
methoxy groups, which would blockthe detoxifying mechanism bythe hydroxyl groups in eugenol.
Equivocal
Nongenotoxic.
Mutagenicity of ammonium molybdate.
Essential micronutrient at physiological levels but may be carcinogenic at high levels.
Carcinogenic
Nongenotoxic.
Structurally related to tetranitromethane and 2-nitropropane, known rodentcarcinogens.
Degeneration of olfactory epithelium in subchronic studies in rats and mice.
Potential for inducing cell proliferation.
Potential activity via its tautomer, CH2=N(OH)=O.
Carcinogenic
Nongenotoxic.
Promoter of liver carcinogenesis in rats.
In subchronic studies, mammary gland hyperplasia was observed in female rats, and clitoral gland
hyperplasia in female mice.
Androgenic steroid; possible human carcinogen.
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Unknown suspicion
Unknown suspicion
Carcinogenic
Carcinogenic
Carcinogenic
Unknown suspicion
Carcinogenic
Carcinogenic
(Continued)
1 108PREDICTING CARCINOGENICITY OF INCHOATE CHEMICALS
Table 1. (Continued.)
Chemical
CAS number Authors' predictions; NCI CSWG's
Route of exposure Rationale/Comments Predictions
Phenolphthalein Carcinogenic Carcinogenic
77-09-8a Clastogenic and induced in vivomicronuclei.
Feed The lactone ring is susceptible to nucleophilic attackwith subsequent formation of a resonance-stabilized
electrophilic intermediate.
Primaclone Carcinogenic Carcinogenic
125833-7a Mutagenic.
Feed Potential forformation of a nitrosamine.
Subchronic studies suggest potential forcarcinogenic effect.
Pyridine Equivocal Unknown suspicion
110-86-1a Nongenotoxic.
Drinking water Metabolism studies suggest possibility of epoxide formation, similartothat observed in that of benzene.
Scopolamine hydrobromidetrihydrate Equivocal Carcinogenic
6533-68-2a Nongenotoxic.
Gavage A suspicion of carcinogenicity may be based on the epoxide moiety and potential forformation ofa
nitrosamine; however, one might expect the epoxide moietyto be unreactive due to its hindered location.
Appears to be readily absorbed and excreted(t1/2 = 3 hr).
Sodium nitrite Equivocal ornoncarcinogenic Unknown suspicion
7632-00-0 Mild squamous hyperplasia in forestomach of rats and mice observed in 90-daywater study.
Drinking water
Tetrahydrofuran Equivocal Unknown suspicion
109g99-ga Nongenotoxic.
Inhalation Epigenetic mechanism.
Structurally related to dioxane.
Little 90-daytoxicity; liver in mice.
Vanadium pentoxide Carcinogenic Unknown suspicion
1314-62-1 Nonmutagenic.
Inhalation In a 90-day study, hyperplasia was observed in respiratory epithelium ofthe nose in male and female rats
and mice.
Essential micronutrient at physiological levels, but may be carcinogenic at high levels.
Xylenesulfonic acid, sodium salt Noncarcinogenic Noncarcinogenic
1300-72-7 [81 Nongenotoxic (did induce SCEs in CHO).
Dermal An isomeric mixture ofxylenes was noncarcinogenic in NTP studies. The sulfonic acid moiety is expected to
exert a detoxifying effect.
aFor most of these chemicals, the results of long-term studies were readily available, or preliminary findings could have been obtained. These results were not consulted
during the prediction process.
relationships do exist for single experi-
ments or individual chemicals. Yet, when
generic statements are proposed, using
induced cell proliferation as a recent and
continuing example of mechanistic-based
carcinogenesis, experimental findings fail
to support the often global notions made
as a result (9,13,35,36).
Thus one often may be misled to
predict carcinogenesis based on observa-
tions from shorter term studies that pur-
portedly are associated with carcinogenesis.
For example, hyaline droplet formation (re
(X2. globulin), induced or enhanced cell
turnover, kidney or urinary bladder
stones, goiter, nephropathy, increased liver
weights, tissue necrosis and adaptive regen-
eration may be placed in this category of
poorly generalized predictors. Associations
with these connectors are typically iden-
tified only after the long-term studies are
completed; yet little is reported about the
myriad times no correlations could be
made for these same observations. Another
example is organ specific DNA adduct for-
mation. This biomarker was highly valued
as a predictor ofcarcinogenesis until more
numerous findings showed organs exhibit-
ing cancer but no adduct formation, and
organs showing DNA adducts but no
cancer. One ofthe values, ofcourse, is as a
biomarker measure ofexposure, which may
prove to be the purpose ofinduced hyaline
droplets ora2.-globulin. 2,3,7,8-Tetrachlorodibenzo-p-dioxin
(TCDD) may be the one chemical that
caused the largest avalanche ofmechanistic
research in a continuing effort to discover
and explain why or how this nonmuta-
genic (37) carcinogen was positive in the
carcinogenesis bioassay (38-40). Clearly
much of this research may have been
stimulated by the Seveso accident in 1976
(41-43). Decades later, however, we remain
uncertain about the mechanism(s) of car-
cinogenesis ofTCDD (44,45), or for any
other chemical carcinogen.
Even when we and others (46) decided
to test benzene, we were challenged because
everyone "knew already" that benzene
caused leukemia in humans, and previous
in vivo tests in animals failed to show
carcinogenic activity (47,48); thus the
following question was raised. why test this
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chemical again and waste further time,
more money, and scarce facilities on a
"known" negative? Yet the major thrust
was not only to determine if indeed ben-
zene would be carcinogenic in more mod-
ern and adequately designed protocols, but
also if this clastogenic human carcinogen
would be detected in our rodent models
and hence would tend to further validate
these models. Despite the many previous
negative (and largely inadequate) studies
on benzene, this chemical was considered
"quite" carcinogenic in our test systems
(49,50). Predictions at the time thus
centered on a negative outcome.
Another example of a known human
carcinogen, and a so far marginal-evidence
carcinogen in rodents is arsenic. After
many years of attempting to have this
metal tested in the NTP protocol, the
bioassay is now being designed under the
rubric of mechanistic studies. The point
here is that some still insist that the bioas-
say is not relevant to humans simply
because this single human carcinogen has
not been shown to be a potent or convinc-
ing carcinogen in rodents. Few mention
that the studies done till now have been
woefully inadequate (51,52). Nonetheless,
we wonder, if inorganic arsenic were on
this exercise list of30 chemicals, how many
of the participants would place it in the
carcinogen category.
Another interesting and controversial
example is trichloroethylene (TCE), a high-
volume solvent and degreaser once used to
decaffeinate coffee. When the first test
results were made available in 1976, the
studies caused considerable debate because
some charged that the TCE- induced car-
cinogenicity was due to or influenced by a
small amount ofepichlorohydrin used as a
stabilizer in the commercial product. First,
TCE was not predicted to cause cancer in
laboratory animals; and second, the pattern
oftumors was different from that seen with
epichlorohydrin alone. Nonetheless, TCE
(without epichlorohydrin) was retested, and
shown again to be carcinogenic. Now we
learn that TCE has been shown to cause
kidney cancer in humans (53), a site com-
mon to that seen previously in animals. This
was the first in a long series ofshort-chain
halogenated aliphatic hydrocarbon solvents
shown to consistently cause tumors in labo-
ratory animals. Without knowing all this
information, we suspect TCE would be
predicted not to be carcinogenic. Ironically,
TCE was replaced with another short-chain
halogenated aliphatic hydrocarbon, methyl-
ene chloride, in decaffeinated coffee (54).
On the other hand, and using what we
know already about empirical or qualitative
chemical carcinogenesis, we have more
predictive conviction on certain chemicals
or classes of chemicals. For instance, we
believe no other benzidine-based dyes,
nitrosamines, aminoanthraquinone pig-
ments, phenylenediamines, anilines, or
benzo[x]pyrenes, among others, need be
tested for carcinogenicity. That is, for these
groups or classes of chemicals, should we
not assume with some degree of scientific
confidence that such chemicals would be
carcinogenic, and not bother with confirm-
atory long-term studies? Ofcourse excep-
tions do and will exist, but perhaps the
producers, or sellers of a new aminoan-
thraquinone dye, for example, should be
obligated to prove noncarcinogenicity
before marketing, rather than force others to
prove carcinogenic activity.
Even in these situations one must be
receptive to contradictions. We felt almost
obligated to predict that emodin (an
anthraquinone) would not possess any car-
cinogenic activity or would simply give a
marginal or equivocal tumor response; we
reached this conclusion because emodin,
although mutagenic to Salmonella, is 1, 3,
8-trihydroxy-6-methyl anthraquinone that
ostensibly would be easily and rapidly
metabolized, conjugated, and excreted.
The more we thought about this, and with
the awareness that 1-hydroxyanthraqui-
none; 1,8-dihydroxyanthraquinone; and
1,2,4-trihydroxyanthraquinone are each
carcinogenic, often with different target
organs, we elected to place emodin in the
anthraquinone-carcinogen category. Our
original predisposition was diverted with
information that we thought was more
important and relevant.
Conversely, from the beginning, we
thought that the parent to this class of
chemicals, anthraquinone, would be
carcinogenic based largely on prechronic
toxic and proliferative effects (which mim-
icked substituted anthraquinones shown to
be carcinogenic), positive mutagenicity
findings, and in vivo micronuclei induc-
tion. However, we decidedly placed more
importance on the likelihood of rapid
metabolism and elimination via 2-hydroxy-
anthraquinone rather than on the shorter
term toxicity test results. Further, we
hypothesized that the observed carcino-
genic activity of the 1- and 8-hydroxyan-
thraquinones may be due to formation ofa
pyrene-type structure via hydrogen bonding
between the hydroxyl and carbonyl func-
tions. Formation ofthis structural moiety is
not possible for 2-hydroxyanthraquinone,
and thus we predicted that anthraquinone
would not be carcinogenic. Whether this
turns out as we predict awaits the real data.
Scopolamine, a naturally occurring
tropane alkaloidal anticholinergic chemi-
cal, proved moderately difficult to predict.
It was virtually devoid of mutagenic activ-
ity in a battery of in vitro (except weakly
positive for chromosomal aberrations in
CHO cells with activation) and in vivo
assays (the mouse peripheral blood micro-
nucleus test). It is rapidly absorbed
(bioavailability = 20-30%), and excreted
(t1/2 = 3 hrs). The CSWG predicted a car-
cinogenic response because scopolamine
contains an aliphatic epoxide moiety and
potential for nitrosation of the amino
group. Yet, none of the short-term tests
revealed mutagenic or alkylating activity.
No toxicology was observed in 16-day or
14-week studies. Also, it is possible that the
epoxide may not be reactive due to its hin-
dered location. Nonetheless, because of
this structural alert we placed this agent in
the marginal or equivocal, borderline-to-
none, category.
At present, and for a relatively long his-
tory, the most certain method by which to
identify potential human carcinogens
comes from exposing laboratory animals to
particular exposure circumstances similar to
those of humans-chemical, mixtures of
chemicals, occupations, work places, life-
styles, personal habits, environmental con-
ditions, and combinations of these for
long periods. Perhaps some day, human
expert-computer-machine learning inter-
active methods will become more adept,
proficient, and accurate at utilizing mini-
mal or no available information to predict
which exposures will be carcinogenic, and
which ofthose will then most likely repre-
sent the greatest carcinogenic risks to
exposed populations. These and other in
vitro and in vivo alternatives have been
searched for over the decades, with some,
albeitlimited, success forcomplementing the
bioassay. None, however, have been consid-
ered successful enough, in our view, to
replace or in most cases even reduce reliance
on the long-term bioassay. Some methods
have striven to simply shorten the exposure
times by developing in vivo assays whereby
select initiators have been used (55).
Despite these noble attempts, the cur-
rent bioassay, with its recognized faults and
shortcomings, has survived both valued
and misguided criticisms to discredit its
worthiness and reliability as well as bal-
anced scientific and public health-based
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efforts to replace, reduce, refine, or eliminate
the use ofand dependence on it.
We hope that new methods will be
developed that can eventually replace the
current bioassay. These methods should be
quicker and less expensive than the current
bioassays, and should use few or no ani-
mals, and be fully predictive of effects in
humans. Meanwhile, and to best protect
public health, exposure circumstances
should be evaluated at an increasing pace
using in vivolong-term bioassays.
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